E
Veru Inc.
VERU
$0.6398
$0.149730.55%
E
Sell
8/30/2024Downgrade
Veru Inc. (VERU) was downgraded to E+ from D- on 8/30/2024 due to a decline in the volatility index, total return index and valuation index.
Veru Inc. (VERU) was downgraded to E+ from D- on 8/30/2024 due to a decline in the volatility index, total return index and valuation index.
D
Sell
8/15/2024Upgraded
Veru Inc. (VERU) was upgraded to D- from E+ on 8/15/2024 due to an increase in the volatility index and solvency index.
Veru Inc. (VERU) was upgraded to D- from E+ on 8/15/2024 due to an increase in the volatility index and solvency index.
E
Sell
8/7/2024Downgrade
Veru Inc. (VERU) was downgraded to E+ from D- on 8/7/2024 due to a decline in the volatility index, growth index and total return index.
Veru Inc. (VERU) was downgraded to E+ from D- on 8/7/2024 due to a decline in the volatility index, growth index and total return index.
D
Sell
7/11/2024Upgraded
Veru Inc. (VERU) was upgraded to D- from E+ on 7/11/2024 due to an increase in the volatility index and total return index.
Veru Inc. (VERU) was upgraded to D- from E+ on 7/11/2024 due to an increase in the volatility index and total return index.
E
Sell
6/25/2024Downgrade
Veru Inc. (VERU) was downgraded to E+ from D- on 6/25/2024 due to a decline in the volatility index.
Veru Inc. (VERU) was downgraded to E+ from D- on 6/25/2024 due to a decline in the volatility index.
D
Sell
6/4/2024Upgraded
Veru Inc. (VERU) was upgraded to D- from E+ on 6/4/2024 due to a significant increase in the growth index, solvency index and volatility index. Total revenue increased 93.18% from $2.14M to $4.14M, the quick ratio increased from 2.58 to 3.92, and earnings per share increased from -$0.0823 to -$0.07.
Veru Inc. (VERU) was upgraded to D- from E+ on 6/4/2024 due to a significant increase in the growth index, solvency index and volatility index. Total revenue increased 93.18% from $2.14M to $4.14M, the quick ratio increased from 2.58 to 3.92, and earnings per share increased from -$0.0823 to -$0.07.
E
Sell
9/19/2023Downgrade
Veru Inc. (VERU) was downgraded to E+ from D- on 9/19/2023 due to a decline in the volatility index.
Veru Inc. (VERU) was downgraded to E+ from D- on 9/19/2023 due to a decline in the volatility index.
D
Sell
8/14/2023Upgraded
Veru Inc. (VERU) was upgraded to D- from E+ on 8/14/2023 due to an increase in the valuation index.
Veru Inc. (VERU) was upgraded to D- from E+ on 8/14/2023 due to an increase in the valuation index.
E
Sell
5/19/2023Downgrade
Veru Inc. (VERU) was downgraded to E+ from D- on 5/19/2023 due to a decline in the valuation index, solvency index and total return index. Debt to equity increased from 0.3 to 0.81, and the quick ratio declined from 1.27 to 0.71.
Veru Inc. (VERU) was downgraded to E+ from D- on 5/19/2023 due to a decline in the valuation index, solvency index and total return index. Debt to equity increased from 0.3 to 0.81, and the quick ratio declined from 1.27 to 0.71.
D
Sell
4/25/2023Upgraded
Veru Inc. (VERU) was upgraded to D- from E+ on 4/25/2023 due to an increase in the volatility index.
Veru Inc. (VERU) was upgraded to D- from E+ on 4/25/2023 due to an increase in the volatility index.
E
Sell
4/10/2023Downgrade
Veru Inc. (VERU) was downgraded to E+ from D- on 4/10/2023 due to a decline in the volatility index and total return index.
Veru Inc. (VERU) was downgraded to E+ from D- on 4/10/2023 due to a decline in the volatility index and total return index.
D
Sell
2/27/2023Downgrade
Veru Inc. (VERU) was downgraded to D- from D on 2/27/2023 due to a large decline in the solvency index, total return index and volatility index.
Veru Inc. (VERU) was downgraded to D- from D on 2/27/2023 due to a large decline in the solvency index, total return index and volatility index.
D
Sell
2/10/2023Upgraded
Veru Inc. (VERU) was upgraded to D from D- on 2/10/2023 due to an increase in the valuation index.
Veru Inc. (VERU) was upgraded to D from D- on 2/10/2023 due to an increase in the valuation index.
D
Sell
12/6/2022Downgrade
Veru Inc. (VERU) was downgraded to D- from D on 12/6/2022 due to a large decline in the efficiency index, growth index and solvency index. EBIT declined 104.7% from -$21.82M to -$44.67M, earnings per share declined from -$0.28 to -$0.5191, and net income declined 84.82% from -$22.2M to -$41.02M.
Veru Inc. (VERU) was downgraded to D- from D on 12/6/2022 due to a large decline in the efficiency index, growth index and solvency index. EBIT declined 104.7% from -$21.82M to -$44.67M, earnings per share declined from -$0.28 to -$0.5191, and net income declined 84.82% from -$22.2M to -$41.02M.
D
Sell
2/11/2022Downgrade
Veru Inc. (VERU) was downgraded to D from D+ on 2/11/2022 due to a noticeable decline in the growth index, efficiency index and total return index. Operating cash flow declined 973.5% from -$806.5 to -$8.66M, EBIT declined 165.19% from -$1.87M to -$4.96M, and earnings per share declined from -$0.0538 to -$0.08.
Veru Inc. (VERU) was downgraded to D from D+ on 2/11/2022 due to a noticeable decline in the growth index, efficiency index and total return index. Operating cash flow declined 973.5% from -$806.5 to -$8.66M, EBIT declined 165.19% from -$1.87M to -$4.96M, and earnings per share declined from -$0.0538 to -$0.08.
D
Sell
12/27/2021Downgrade
Veru Inc. (VERU) was downgraded to D+ from C- on 12/27/2021 due to a noticeable decline in the total return index.
Veru Inc. (VERU) was downgraded to D+ from C- on 12/27/2021 due to a noticeable decline in the total return index.
C
Hold
12/9/2021Upgraded
Veru Inc. (VERU) was upgraded to C- from D+ on 12/9/2021 due to an increase in the total return index and valuation index.
Veru Inc. (VERU) was upgraded to C- from D+ on 12/9/2021 due to an increase in the total return index and valuation index.
D
Sell
12/6/2021Upgraded
Veru Inc. (VERU) was upgraded to D+ from D on 12/6/2021 due to a significant increase in the efficiency index and valuation index.
Veru Inc. (VERU) was upgraded to D+ from D on 12/6/2021 due to a significant increase in the efficiency index and valuation index.
D
Sell
11/23/2021Upgraded
Veru Inc. (VERU) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index and volatility index.
Veru Inc. (VERU) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index and volatility index.
D
Sell
11/8/2021Downgrade
Veru Inc. (VERU) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index, volatility index and solvency index.
Veru Inc. (VERU) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index, volatility index and solvency index.
D
Sell
5/17/2021Downgrade
Veru Inc. (VERU) was downgraded to D from C- on 5/17/2021 due to a significant decline in the growth index, efficiency index and total return index. Operating cash flow declined 492.82% from $659.2 to -$2.59M, EBIT declined 289.37% from $777 to -$1.47M, and earnings per share declined from $0.23 to -$0.04.
Veru Inc. (VERU) was downgraded to D from C- on 5/17/2021 due to a significant decline in the growth index, efficiency index and total return index. Operating cash flow declined 492.82% from $659.2 to -$2.59M, EBIT declined 289.37% from $777 to -$1.47M, and earnings per share declined from $0.23 to -$0.04.
C
Hold
4/16/2021Downgrade
Veru Inc. (VERU) was downgraded to C- from C on 4/16/2021 due to a noticeable decline in the total return index and volatility index.
Veru Inc. (VERU) was downgraded to C- from C on 4/16/2021 due to a noticeable decline in the total return index and volatility index.
C
Hold
2/12/2021Upgraded
Veru Inc. (VERU) was upgraded to C from D on 2/12/2021 due to a significant increase in the total return index, solvency index and efficiency index. Net income increased 245.6% from -$11.83M to $17.23M, the quick ratio increased from 1.28 to 2.06, and total capital increased 45.96% from $44.28M to $64.63M.
Veru Inc. (VERU) was upgraded to C from D on 2/12/2021 due to a significant increase in the total return index, solvency index and efficiency index. Net income increased 245.6% from -$11.83M to $17.23M, the quick ratio increased from 1.28 to 2.06, and total capital increased 45.96% from $44.28M to $64.63M.
D
Sell
12/5/2019Downgrade
Veru Inc. (VERU) was downgraded to D from D+ on 12/5/2019 due to a large decline in the total return index and valuation index.
Veru Inc. (VERU) was downgraded to D from D+ on 12/5/2019 due to a large decline in the total return index and valuation index.
D
Sell
10/31/2019Upgraded
Veru Inc. (VERU) was upgraded to D+ from D on 10/31/2019 due to a significant increase in the growth index, total return index and volatility index. Operating cash flow increased 78.86% from -$2.5M to -$527.6, total revenue increased 39.43% from $6.98M to $9.73M, and earnings per share increased from -$0.0643 to -$0.0441.
Veru Inc. (VERU) was upgraded to D+ from D on 10/31/2019 due to a significant increase in the growth index, total return index and volatility index. Operating cash flow increased 78.86% from -$2.5M to -$527.6, total revenue increased 39.43% from $6.98M to $9.73M, and earnings per share increased from -$0.0643 to -$0.0441.
D
Sell
9/4/2018Downgrade
Veru Inc. (VERU) was downgraded to D from D+ on 9/4/2018 due to a decline in the total return index.
Veru Inc. (VERU) was downgraded to D from D+ on 9/4/2018 due to a decline in the total return index.
D
Sell
8/17/2018Upgraded
Veru Inc. (VERU) was upgraded to D+ from D on 8/17/2018 due to a large increase in the total return index, volatility index and valuation index.
Veru Inc. (VERU) was upgraded to D+ from D on 8/17/2018 due to a large increase in the total return index, volatility index and valuation index.
D
Sell
11/30/2017Downgrade
Veru Inc. (VERU) was downgraded to D from D+ on 11/30/2017 due to a decline in the volatility index.
Veru Inc. (VERU) was downgraded to D from D+ on 11/30/2017 due to a decline in the volatility index.
D
Sell
10/6/2017Upgraded
Veru Inc. (VERU) was upgraded to D+ from D on 10/6/2017 due to a substantial increase in the total return index and volatility index.
Veru Inc. (VERU) was upgraded to D+ from D on 10/6/2017 due to a substantial increase in the total return index and volatility index.
D
Sell
10/20/2016Downgrade
The Female Health Company (FHCO) was downgraded to D from D+ on 10/20/2016 due to a decline in the volatility index and total return index.
The Female Health Company (FHCO) was downgraded to D from D+ on 10/20/2016 due to a decline in the volatility index and total return index.
D
Sell
10/5/2016Upgraded
The Female Health Company (FHCO) was upgraded to D+ from D on 10/5/2016 due to a large increase in the growth index. Earnings per share increased from $0.0012 to $0.0199, EBIT increased 1,105.26% from $70.4 to $848.5, and operating cash flow increased 147.71% from -$880.4 to $420.
The Female Health Company (FHCO) was upgraded to D+ from D on 10/5/2016 due to a large increase in the growth index. Earnings per share increased from $0.0012 to $0.0199, EBIT increased 1,105.26% from $70.4 to $848.5, and operating cash flow increased 147.71% from -$880.4 to $420.
D
Sell
5/3/2016Downgrade
The Female Health Company (FHCO) was downgraded to D from D+ on 5/3/2016 due to a major decline in the growth index and efficiency index. Operating cash flow declined 104.17% from -$431.2 to -$880.4, net income declined 97.65% from $1.49M to $35, and earnings per share declined from $0.05 to $0.0012.
The Female Health Company (FHCO) was downgraded to D from D+ on 5/3/2016 due to a major decline in the growth index and efficiency index. Operating cash flow declined 104.17% from -$431.2 to -$880.4, net income declined 97.65% from $1.49M to $35, and earnings per share declined from $0.05 to $0.0012.
D
Sell
3/11/2016Downgrade
The Female Health Company (FHCO) was downgraded to D+ from C+ on 3/11/2016 due to a major decline in the volatility index, total return index and valuation index.
The Female Health Company (FHCO) was downgraded to D+ from C+ on 3/11/2016 due to a major decline in the volatility index, total return index and valuation index.
C
Hold
2/4/2016Upgraded
The Female Health Company (FHCO) was upgraded to C+ from C on 2/4/2016 due to a major increase in the valuation index, growth index and efficiency index. EBIT increased 214.28% from $761.3 to $2.39M, earnings per share increased from $0.0207 to $0.05, and net income increased 112.13% from $702.6 to $1.49M.
The Female Health Company (FHCO) was upgraded to C+ from C on 2/4/2016 due to a major increase in the valuation index, growth index and efficiency index. EBIT increased 214.28% from $761.3 to $2.39M, earnings per share increased from $0.0207 to $0.05, and net income increased 112.13% from $702.6 to $1.49M.
C
Hold
7/31/2015Downgrade
The Female Health Company (FHCO) was downgraded to C from C+ on 7/31/2015 due to a large decline in the growth index and efficiency index. Operating cash flow declined 87.05% from -$1.61M to -$208.4, EBIT declined 50.71% from $2.95M to $1.45M, and earnings per share declined from $0.0585 to $0.04.
The Female Health Company (FHCO) was downgraded to C from C+ on 7/31/2015 due to a large decline in the growth index and efficiency index. Operating cash flow declined 87.05% from -$1.61M to -$208.4, EBIT declined 50.71% from $2.95M to $1.45M, and earnings per share declined from $0.0585 to $0.04.
C
Hold
6/22/2015Upgraded
The Female Health Company (FHCO) was upgraded to C+ from C on 6/22/2015 due to a significant increase in the valuation index, growth index and efficiency index. Earnings per share increased from $0.0282 to $0.0585, net income increased 107.18% from $804.9 to $1.67M, and EBIT increased 102.88% from $1.45M to $2.95M.
The Female Health Company (FHCO) was upgraded to C+ from C on 6/22/2015 due to a significant increase in the valuation index, growth index and efficiency index. Earnings per share increased from $0.0282 to $0.0585, net income increased 107.18% from $804.9 to $1.67M, and EBIT increased 102.88% from $1.45M to $2.95M.
C
Hold
1/21/2015Upgraded
The Female Health Company (FHCO) was upgraded to C from C- on 1/21/2015 due to an increase in the valuation index and total return index.
The Female Health Company (FHCO) was upgraded to C from C- on 1/21/2015 due to an increase in the valuation index and total return index.
C
Hold
12/4/2014Downgrade
The Female Health Company (FHCO) was downgraded to C- from C+ on 12/4/2014 due to a significant decline in the valuation index, growth index and dividend index. Earnings per share declined from $0.04 to -$0.0201, EBIT declined 123.8% from $2.03M to -$482.6, and total revenue declined 29.7% from $7.9M to $5.55M.
The Female Health Company (FHCO) was downgraded to C- from C+ on 12/4/2014 due to a significant decline in the valuation index, growth index and dividend index. Earnings per share declined from $0.04 to -$0.0201, EBIT declined 123.8% from $2.03M to -$482.6, and total revenue declined 29.7% from $7.9M to $5.55M.
C
Hold
9/9/2014Downgrade
The Female Health Company (FHCO) was downgraded to C+ from B- on 9/9/2014 due to a large decline in the total return index and volatility index.
The Female Health Company (FHCO) was downgraded to C+ from B- on 9/9/2014 due to a large decline in the total return index and volatility index.
B
Buy
6/19/2014Upgraded
The Female Health Company (FHCO) was upgraded to B- from C+ on 6/19/2014 due to an increase in the valuation index and dividend index.
The Female Health Company (FHCO) was upgraded to B- from C+ on 6/19/2014 due to an increase in the valuation index and dividend index.
C
Hold
5/5/2014Downgrade
The Female Health Company (FHCO) was downgraded to C+ from B- on 5/5/2014 due to a substantial decline in the growth index, valuation index and total return index. Operating cash flow declined 101.34% from $1.18M to -$15.8, earnings per share declined from $0.05 to $0.01, and EBIT declined 49.79% from $1.58M to $795.2.
The Female Health Company (FHCO) was downgraded to C+ from B- on 5/5/2014 due to a substantial decline in the growth index, valuation index and total return index. Operating cash flow declined 101.34% from $1.18M to -$15.8, earnings per share declined from $0.05 to $0.01, and EBIT declined 49.79% from $1.58M to $795.2.
B
Buy
4/17/2014Downgrade
The Female Health Company (FHCO) was downgraded to B- from B on 4/17/2014 due to a decline in the total return index, volatility index and valuation index.
The Female Health Company (FHCO) was downgraded to B- from B on 4/17/2014 due to a decline in the total return index, volatility index and valuation index.
B
Buy
4/2/2014Upgraded
The Female Health Company (FHCO) was upgraded to B from B- on 4/2/2014 due to an increase in the volatility index.
The Female Health Company (FHCO) was upgraded to B from B- on 4/2/2014 due to an increase in the volatility index.
B
Buy
3/11/2014Downgrade
The Female Health Company (FHCO) was downgraded to B- from B on 3/11/2014 due to a major decline in the volatility index.
The Female Health Company (FHCO) was downgraded to B- from B on 3/11/2014 due to a major decline in the volatility index.
NASDAQ
04/01/2025 4:00PM Eastern
Quotes delayed
